NEXT GENERATION DNA VACCINES II: “This approach offers a number of potential advantages over traditional approaches, including the stimulation of both B- and T-cell responses, improved vaccine stability, the absence of any infectious agent and the relative ease of large-scale manufacture.”
http://www.who.int/biologicals/areas/vaccines/dna/en/
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022